Editorial
doi: 10.1200/JCO.2011.37.1377.
Epub 2011 Oct 11.
More is not necessarily better when treating Hodgkin's lymphoma
- PMID: 21990411
- DOI: 10.1200/JCO.2011.37.1377
Item in Clipboard
Editorial
More is not necessarily better when treating Hodgkin's lymphoma
J Clin Oncol.
.
No abstract available
Comment in
-
On the role of consolidation radiotherapy in advanced-stage Hodgkin's lymphoma.J Clin Oncol. 2012 Apr 1;30(10):1146-7; author reply 1147. doi: 10.1200/JCO.2011.41.2627. Epub 2012 Feb 27. J Clin Oncol. 2012. PMID: 22370311 No abstract available.
Comment on
-
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.J Clin Oncol. 2011 Nov 10;29(32):4234-42. doi: 10.1200/JCO.2010.33.9549. Epub 2011 Oct 11. J Clin Oncol. 2011. PMID: 21990399 Clinical Trial.
-
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.J Clin Oncol. 2011 Nov 10;29(32):4227-33. doi: 10.1200/JCO.2010.30.9799. Epub 2011 Oct 11. J Clin Oncol. 2011. PMID: 21990405 Clinical Trial.
Similar articles
-
Hodgkin's lymphoma--the great teacher.N Engl J Med. 2011 Jul 21;365(3):264-5. doi: 10.1056/NEJMe1104576. N Engl J Med. 2011. PMID: 21774715 No abstract available.
-
Escalated BEACOPP in advanced Hodgkin's lymphoma.Lancet. 2012 May 12;379(9828):1767-8. doi: 10.1016/S0140-6736(12)60153-6. Epub 2012 Apr 4. Lancet. 2012. PMID: 22480757 No abstract available.
-
ABVD, the Stanford V regimen, and BEACOPP for Hodgkin's lymphoma: what should an oncologist do?Clin Lymphoma. 2005 Jun;6(1):50-1. doi: 10.3816/clm.2005.n.028. Clin Lymphoma. 2005. PMID: 15989708 Review. No abstract available.
-
Greater curability in advanced Hodgkin's disease?Cancer J Sci Am. 1999 Sep-Oct;5(5):264-5. Cancer J Sci Am. 1999. PMID: 10526665 No abstract available.
-
Advanced Hodgkin's disease: ABVD is better, yet is not good enough!J Clin Oncol. 2003 Feb 15;21(4):583-5. doi: 10.1200/JCO.2003.11.072. J Clin Oncol. 2003. PMID: 12586791 Review. No abstract available.
Cited by
-
Long-term structured follow-up is essential after curative cancer treatment.Dtsch Arztebl Int. 2014 Jan 6;111(1-2):1-2. doi: 10.3238/arztebl.2014.0001. Dtsch Arztebl Int. 2014. PMID: 24565269 Free PMC article. No abstract available.
-
Brentuximab vedotin treatment for primary refractory hodgkin lymphoma.Case Rep Hematol. 2013;2013:351292. doi: 10.1155/2013/351292. Epub 2013 Oct 2. Case Rep Hematol. 2013. PMID: 24198983 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
